Nadine Alwawi Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11051 Catherine Dr, Palos Hills, IL 60465 Phone: 708-860-7354 |
Betty Parhas Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11053 Southwest Hwy, Palos Hills, IL 60465 Phone: 708-974-0532 |
Dr. Hamza Awadallah, PHARMD, MBA Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11164 Southwest Hwy, Palos Hills, IL 60465 Phone: 708-541-1000 Fax: 708-666-8112 |
Alan J Dempsey, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11053 Southwest Hwy, Palos Hills, IL 60465 Phone: 708-974-0532 Fax: 708-974-0641 |
News Archive
Late-breaking results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.
Urgent need for better disease prevention policies targeting poor diet, smoking, alcohol, high blood pressure and physical inactivity, as well as increased investment in health and social care.
› Verified 3 days ago